Evidence map›Paper›PMID 36431242›Full record

ArticleJournal of clinical medicine2022

Management of Endometrial Cancer: French Society of Onco-Gynecology's Evaluation through a Delphi Survey.

Carolin Marti, Elise Deluche, Floriane Jochum, Sofiane Bendifallah, Henri Azais, Jonas Deidier, Vincent Cockenpot, Inès Menoux, Vincent Balaya, Sarah Betrian and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Carolin MartiFaculty of Biology and Medicine, University of Lausanne (UNIL), 1015 Lausanne, Switzerland.
Elise DelucheDepartment of Medical Oncology, CHU Limoges, 87000 Limoges, France.
Floriane JochumResidual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, 75005 Paris, France.
Sofiane BendifallahDepartment of Gynecology, Tenon Hospital, 75020 Paris, France.
Henri AzaisGynecologic and Breast Oncologic Surgery Department, Georges Pompidou European Hospital, 75015 Paris, France.ORCID 0000-0002-6855-9754
Jonas DeidierDepartment of Radiology, Hôpital Universitaire Paris Ouest Site G Pompidou APHP, 75015 Paris, France.
Vincent CockenpotDepartment of Pathology, Centre Léon Bérard, 69008 Lyon, France.ORCID 0000-0002-7470-4436
Inès MenouxDepartment of Radiotherapy, ICANS-Strasbourg-Europe Cancer Institute, 67200 Strasbourg, France.
Vincent BalayaDepartment of Gynecology, Foch Hospital, 92150 Suresnes, France.ORCID 0000-0002-7561-239X
Sarah BetrianDepartment of Medical Oncology, IUCT Oncopole, 31059 Toulouse, France.
Cyrus ChargariDepartment of Radiation Oncology, Gustave Roussy Cancer Campus, 94850 Villejuif, France.ORCID 0000-0003-0119-3695
Sébastien GouyDepartment of Surgical Gynecology Oncology, Gustave Roussy Cancer Campus, 94850 Villejuif, France.
Catherine GenestieDepartment of Pathology, Gustave Roussy Cancer Campus, 94850 Villejuif, France.
Anis FekiDepartment of Gynecology and Obstetrics, HFR Fribourg-Hôpital Cantonal, 1708 Fribourg, Switzerland.ORCID 0000-0002-9817-9445
Catherine UzanDepartement of Breast and Gynecologic Surgery, AP-HP, Hôpital de la Pitié Salpêtrière, 75013 Paris, France.
Frederic GuyonDepartment of Surgical Oncology, Bergonié Institute, 33076 Bordeaux, France.
Mojgan Devouassoux-ShisheboranDepartment of Pathology, Hospices Civiles de Lyon, 69002 Lyon, France.
Noémie BodyDepartment of Surgical Oncology, Institut de Cancérologie de l'Ouest (ICO), 49055 Angers, France.
Cherif AkladiosDepartment of Gynecology and Obstetrics, Hopitaux Universitaires de Strasbourg, 67091 Strasbourg, France.
Patrice MathevetFaculty of Biology and Medicine, University of Lausanne (UNIL), 1015 Lausanne, Switzerland.
Benedetta GuaniFaculty of Biology and Medicine, University of Lausanne (UNIL), 1015 Lausanne, Switzerland.ORCID 0000-0003-4498-3734
On Behalf Of The Sfog And The Sfog Campus

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our aim was to assess the opinion of a panel of experts and obtain a consensus on the management of endometrial cancer in France and French Switzerland. A Delphi survey was carried out among a panel of French and French-speaking Swiss experts. The first questionnaire included 65 questions divided into eight categories: characterization of experts, histo-molecular characteristics and radiological data of endometrial cancer, and management of low-risk, intermediate-risk, intermediate-high-risk, high-risk, and metastatic cancers. The experts were asked to reply on a 9-point scale, both on the validity and the clarity of each question. After the answers were analyzed, a second questionnaire was sent to the same experts. The study took place between December 2021 and March 2022. Further, 58 (57.4%) of the 101 experts responded in the first round, and 39 recommendations were obtained (60%). Six questions were voted redundant and 20 discordant. These questions were reformulated, and, at the end of the second round, 17 recommendations were validated (85%). In total, the study presents an analysis of 56 questions and related responses. Expert advice helps to clarify non-consensual issues, standardize the management of endometrial cancer, and optimize clinical practices.

Indexed as

Delphi procedureendometrial cancerendometrial cancer guidelinesSFOG guidelines

Identifiers

PMID36431242
PMCPMC9699020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.